{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:56:10Z","timestamp":1793822170315,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.contraception.2025.111012","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:07:59Z","timestamp":1751886479000},"page":"111012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Safety of hormonal contraception among women with liver disease: an updated systematic review"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9602-3674","authenticated-orcid":false,"given":"Nathalie","family":"Kapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi K.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Garbarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kortsmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.111012_bib1","unstructured":"Centers for Disease Control and Prevention. Chronic liver disease and cirrhosis. \u3008https:\/\/www.cdc.gov\/nchs\/fastats\/liver-disease.htm\u3009 (accessed December 23, 2024)."},{"key":"10.1016\/j.contraception.2025.111012_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.31559","article-title":"Reproductive health and liver disease: practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Sarkar","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.contraception.2025.111012_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5122(96)01031-6","article-title":"Effects of androgens on haemostasis","volume":"24","author":"Winkler","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2025.111012_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2025.111012_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5122(96)00994-2","article-title":"Effects of progestogens on haemostasis","volume":"24","author":"Kuhl","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2025.111012_bib6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2007-0044","article-title":"Formation of ethinyl estradiol in women during treatment with norethindrone acetate","volume":"92","author":"Chu","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2025.111012_bib7","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3748\/wjg.v28.i14.1384","article-title":"Hepatocellular adenoma: where are we now?","volume":"28","author":"Wang","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.contraception.2025.111012_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2023.03.006","article-title":"EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.contraception.2025.111012_bib9","series-title":"StatPearls [Internet]","article-title":"Viral hepatitis\u00a0[Updated 2024 Mar 10]","author":"Mehta","year":"2024"},{"key":"10.1016\/j.contraception.2025.111012_bib10","unstructured":"World Health Organization. Hepatitis. \u3008https:\/\/www.who.int\/health-topics\/hepatitis#tab=tab_1\u3009 (accessed December 23, 2024)."},{"key":"10.1016\/j.contraception.2025.111012_bib11","article-title":"Prevalence of hepatitis B virus and its associated factors among pregnant women attending antenatal care in Ambo town, Central Ethiopia: a cross-sectional study","volume":"15","author":"Wakjira","year":"2022","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.contraception.2025.111012_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cid\/ciz841","article-title":"Trends in Hepatitis B infection and immunity among women of childbearing age in the United States","volume":"71","author":"Kushner","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.contraception.2025.111012_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/M16-2350","article-title":"Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014","volume":"166","author":"Ly","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2025.111012_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111012_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.111012_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.contraception.2009.04.007","article-title":"The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review","volume":"80","author":"Kapp","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111012_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.contraception.2009.01.021","article-title":"Hormonal contraceptive use among women with liver tumors: a systematic review","volume":"80","author":"Kapp","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111012_bib18","unstructured":"Curtis K, Nguyen A, Kapp N, Whiteman M. Safety of hormonal contraception among women with liver disease: a systematic review. crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42019127163 (accessed December 23, 2024)."},{"key":"10.1016\/j.contraception.2025.111012_bib19","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111012_bib20","unstructured":"Veritas Health Innovation. Covidence systematic review software. \u3008https:\/\/www.covidence.org\/\u3009 (accessed December 23, 2024)."},{"key":"10.1016\/j.contraception.2025.111012_bib21","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)","article-title":"Chapter 25: Assessing risk of bias in a non-randomized study","author":"Sterne","year":"2022"},{"key":"10.1016\/j.contraception.2025.111012_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111012_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.111012_bib24","unstructured":"GRADEpro Guideline Development Tool [Software]. 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). https:\/\/www.gradepro.org\/."},{"key":"10.1016\/j.contraception.2025.111012_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1478-3231.2011.02667.x","article-title":"Can a decision-making model be justified in the management of hepatocellular adenoma?","volume":"32","author":"van Aalten","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.contraception.2025.111012_bib26","first-page":"1008","article-title":"[Natural history of focal nodular hyperplasia. A retrospective study of 44 cases]","volume":"25","author":"D'Halluin","year":"2001","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.contraception.2025.111012_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.32734","article-title":"Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation","volume":"77","author":"Demory","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.contraception.2025.111012_bib28","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.20463","article-title":"Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure","volume":"40","author":"Di Martino","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.contraception.2025.111012_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.3.5774.561","article-title":"Oral contraceptives after liver disease","volume":"3","author":"Eisalo","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.111012_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0971-3026.101084","article-title":"Understanding the natural history of focal nodular hyperplasia in the liver with MRI","volume":"22","author":"Halankar","year":"2012","journal-title":"Indian J Radiol Imaging"},{"key":"10.1016\/j.contraception.2025.111012_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/liv.14074","article-title":"The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: a retrospective cohort study","volume":"39","author":"Haring","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.contraception.2025.111012_bib32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0140-6736(05)61451-1","article-title":"Oral contraceptive intake in women with focal nodular hyperplasia of the liver","volume":"352","author":"Mathieu","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2025.111012_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0016-5085(00)70262-9","article-title":"Oral contraceptive use and focal nodular hyperplasia of the liver","volume":"118","author":"Mathieu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.contraception.2025.111012_bib34","doi-asserted-by":"crossref","first-page":"109915","DOI":"10.1016\/j.contraception.2022.11.006","article-title":"Influence of progestin-only hormonal use on hepatocellular adenomas: a retrospective cohort study","volume":"199","author":"Qureshy","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111012_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jama.1975.03260090045021","article-title":"Oral contraceptives in acute viral hepatitis","volume":"233","author":"Schweitzer","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2025.111012_bib36","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1177\/00031348211011084","article-title":"A multicenter, 10-year experience with hepatocellular adenoma: risk factors and disease course","volume":"88","author":"Silva","year":"2022","journal-title":"Am Surg"},{"key":"10.1016\/j.contraception.2025.111012_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1099-1557(200005\/06)9:3<245::AID-PDS500>3.0.CO;2-7","article-title":"Safety of hormonal steroid contraceptive use for hepatitis B virus carrier women","volume":"9","author":"Wang","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.contraception.2025.111012_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0010-7824(82)90173-1","article-title":"Effects of oral contraception on liver function tests and serum proteins in women with past viral hepatitis","volume":"26","author":"Shaaban","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111012_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2559.2001.01172.x","article-title":"Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis","volume":"39","author":"Libbrecht","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.contraception.2025.111012_bib40","unstructured":"Centers for Disease Control and Prevention. Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/156516\u3009 (accessed December 23, 2024)."},{"key":"10.1016\/j.contraception.2025.111012_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/hep.14.41","article-title":"Hepatocellular adenoma management: advances but still a long way to go","volume":"2","author":"Blanc","year":"2015","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.contraception.2025.111012_bib42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2025.111012_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111012_bib44","first-page":"CD011054","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111012_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00993","article-title":"Oral contraceptive use and increased risk of stroke: a dose-response meta-analysis of observational studies","volume":"10","author":"Li","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.contraception.2025.111012_bib46","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111012_bib47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111012_bib48","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.contraception.2025.111012_bib49","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425002033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425002033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:16:44Z","timestamp":1780712204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S0010782425002033"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111012","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of hormonal contraception among women with liver disease: an updated systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111012"}}